Results 11 to 20 of about 57,421 (320)
Frontiers in Endocrinology, 2022 Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) are essential to normal growth, metabolism, and body composition, but in acromegaly, excesses of these hormones strikingly alter them.
Pamela U. Freda
doaj +3 more sources
BMC Endocrine Disorders, 2020 Background Acromegaly patients managed on Somatostatin receptor ligands (SRLs), the most common first-line pharmacotherapy for acromegaly, may still experience acromegaly symptoms such as headache, sweating, fatigue, soft tissue swelling, and joint pain,
Eliza B. Geer +8 more
doaj +2 more sources
Insulin Resistance in Patients With Acromegaly
Frontiers in Endocrinology, 2019 Acromegaly is characterized by chronic overproduction of growth hormone (GH) that leads to insulin resistance, glucose intolerance and, ultimately, diabetes. The GH-induced sustained stimulation of lipolysis plays a major role not only in the development
Greisa Vila +3 more
doaj +2 more sources
E-cadherin expression is associated with somatostatin analogue response in acromegaly [PDF]
Journal of Cellular and Molecular Medicine, 2018 Acromegaly is a rare disease resulting from hypersecretion of growth hormone (GH) and insulin‐like growth factor 1 (IGF1) typically caused by pituitary adenomas, which is associated with increased mortality and morbidity. Somatostatin analogues (SSAs)
Cano, David A. +10 more
core +2 more sources
Pathogenesis of Acromegaly [PDF]
The Journal of Nervous and Mental Disease, 1895 n ...
ONUF
openalex +4 more sources
Consensus on criteria for acromegaly diagnosis and remission
Pituitary, 2023 Purpose The 14th Acromegaly Consensus Conference was convened to consider biochemical criteria for acromegaly diagnosis and evaluation of therapeutic efficacy. Methods Fifty-six acromegaly experts from 16 countries reviewed and discussed current evidence
Andrea Giustina +52 more
semanticscholar +1 more source
Association of Epicardial Adipose Tissue Thickness with Cardiovascular Risk in Acromegaly
Medeniyet Medical Journal, 2022 Objective: Acromegaly is a rare disease associated with increased mortality. Reports on coronary artery disease in acromegaly are controversial. This study aimed to investigate the possible association of epicardial adipose tissue thickness with ...
Bulent CAN +3 more
doaj +1 more source
The Journal of Clinical Endocrinology & Metabolism, 1997 This review presents a collection of uncommon aspects of acromegaly based on extensive experience of the authors.
COLAO, ANNAMARIA +3 more
openaire +5 more sources
Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine [PDF]
Endocrinology and Metabolism, 2023 The clinical characteristics and prognoses of acromegaly vary among patients. Assessment of current and novel predictors can lead to multilevel categorization of patients, allowing integration into new clinical guidelines and a reduction in the increased
Kyungwon Kim +2 more
doaj +1 more source